Model
Edge
PDL BioPharma, Inc.
0000882104
Filing Type
10-K
Filing Date
3/10/2020
Updated
3/11/20, 10:16 AM
Filing
10-K
Earnings Release
Exhibits
10-K
FY 2019
EX-4.8
DESCRIPTION OF REGISTRANTS SECURITIES
EX-10.66
FIFTH AMENDEMENT TO LEASE AGREEMENT
EX-10.67
SEVERANCE PLAN
EX-10.68
FORM OF RESTRICTED STOCK AGREEMENT
EX-10.69
FORM OF RESTRICTED STOCK AGREEMENT AMENDMENT ACKNOWLEDGEMENT
EX-10.70
FORM OF STOCK OPTION AGREEMENT
EX-10.71
FORM OF STOCK OPTION AGREEMENT AMENDMENT ACKNOWLEDGEMENT
EX-10.72
FORM OF STOCK OPTION GRANT NOTICE SUPPLEMENT
EX-10.73
FORM OF NONSTATUTORY INDUCMENT STOCK OPTION AGREEMENT
EX-10.74
FORM OF NONSTATUTORY INDUCMENT STOCK OPTION AGREEMENT NOTICE SUPPPLEMENT
EX-10.75
FORM OF INDUCEMENT RESTRICTED STOCK AGREEMENT
EX-10.76
WIND DOWN RETENTION PLAN
EX-21.1
SUBSIDIARIES OF THE REGISTRANT
EX-23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
EX-31.1
CERTIFICATION
EX-31.2
CERTIFICATION
EX-32.1
CERTIFICATION
EX-101.INS
XBRL INSTANCE DOCUMENT
GRAPHIC
GRAPHIC